Fucosylation of anti-dsDNA IgG1 correlates with disease activity of treatment-naïve systemic lupus erythematosus patients

J Han, Z Zhou, R Zhang, Y You, Z Guo, J Huang… - …, 2022 - thelancet.com
Summary Background Systemic Lupus Erythematosus (SLE) is a complex and
heterogeneous autoimmune disease mediated by quantities of autoantibodies in which anti …

Beyond titer: Expanding the scope of clinical autoantibody testing

RS Treger, SL Fink - The Journal of Applied Laboratory …, 2022 - academic.oup.com
Background Autoantibodies that bind self-antigens are a hallmark of autoimmune diseases,
but can also be present in healthy individuals. Clinical assays that detect and titer antigen …

[PDF][PDF] Association of the serum IgG glycosylation with disease activity of anti-transcription intermediary factor 1 gamma positive dermatomyositis

X Li, J Bai, S Li, M Li, X Zeng, Q Wang… - Clin Exp …, 2022 - clinexprheumatol.org
Objective Dermatomyositis (DM) is an idiopathic inflammatory myopathy characterised by
the presence of a variety of myositisspecific autoantibodies (MSA) in the circulation. As one …

Investigation of the Serological Changes that Discriminate Asymptomatic Antinuclear Antibody Positive Individuals from Systemic Autoimmune Rheumatic Disease …

C Muñoz-Grajales - 2022 - search.proquest.com
The Antinuclear antibody (ANA) associated Systemic Autoimmune Rheumatic Diseases
(SARDs) are chronic rheumatic disorders associated with high morbidity. Many patients with …